Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 54635 [E8-22066]

Download as PDF Federal Register / Vol. 73, No. 184 / Monday, September 22, 2008 / Notices notice of proposed action and an opportunity for hearing or a notice of hearing is not warranted. Notice is hereby given of the right of interested persons to request a hearing on whether the action should be rescinded or modified. Further Information: For further details with respect to this action, see the application dated September 26, 2007, and Amendment No. 1, which are available electronically, at NRC’s Electronic Reading Room, at: https://www.nrc.gov/ reading-rm/adams.html. From this site, you can access NRC’s Agencywide Document Access and Management System (ADAMS), which provides text and image files of NRC’s public documents. The ADAMS accession number for the application is ML072820139 and the ADAMS accession number for Amendment No. 1 is ML082560545. If you do not have access to ADAMS, or if there are problems in accessing the documents located in ADAMS, contact NRC’s Public Document Room (PDR) Reference staff at 1–800–397–4209, 301–415–4737, or by e-mail to pdr@nrc.gov. These documents may also be viewed electronically on the public computers located at NRC’s PDR, O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, MD 20852. The PDR reproduction contractor will copy documents, for a fee. Dated at Rockville, Maryland, this 12th day of September, 2008. For the Nuclear Regulatory Commission. Kevin M. Witt, Project Manager, Licensing Branch, Division of Spent Fuel Storage and Transportation, Office of Nuclear Material Safety and Safeguards. [FR Doc. E8–22048 Filed 9–19–08; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. sroberts on PROD1PC70 with NOTICES AGENCY: SUMMARY: NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) October 27–28, 2008. A sample of agenda items to be discussed during the public session includes: (1) ACMUI subcommittee reports on cesium chloride (CsCl), permanent implant brachytherapy rulemaking, and fingerprinting; (2) Y–90 microsphere VerDate Aug<31>2005 19:11 Sep 19, 2008 Jkt 214001 brachytherapy licensing guidance; (3) potential changes to 10 CFR Parts 20 and 35; (4) patient needs, concerns, and rights in radiation medicine; (5) infiltration of fluorine-18 (F–18) and therapeutic radiopharmaceuticals as medical events; (6) status of recommendations for modifying training and experience attestation requirements; (7) status of technical basis for the Petition for Rulemaking (PRM) 35–20 (Ritenour) and follow-up; (8) Potential rulemaking and associated Regulatory Issue Summary (RIS) regarding multiple RSOs on a medical-use license; (9) status of current and future 10 CFR Part 35 rulemaking; and (10) medical isotope shortages. A copy of the agenda will be available at https://www.nrc.gov/readingrm/doc-collections/acmui/agenda or by e-mailing Ms. Ashley Tull at the contact information below. Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of Byproduct Material. Date and Time for Closed Sessions: October 27, 2008 from 8 a.m. to 9 a.m. This session will be closed so that ACMUI can discuss internal Committee business and receive annual ethics training. Date and Time for Open Sessions: October 27, 2008, from 9 a.m. to 5 p.m. and October 28, 2008, from 8 a.m. to 4 p.m. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T– 2B3, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting should contact Ms. Tull using the information below. FOR FURTHER INFORMATION CONTACT: Ashley M. Tull, e-mail: ashley.tull@nrc.gov, telephone: (240) 888–7129. Conduct of the Meeting Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Tull at the contact information listed above. All submittals must be received by October 20, 2008, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The transcript will be available on ACMUI’s Web site (https://www.nrc.gov/ PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 54635 reading-rm/doc-collections/acmui/tr/) on or about January 27, 2009. A meeting summary will be available on or about December 11, 2008. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Tull of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10, U.S. Code of Federal Regulations, Part 7. Dated: September 16, 2008. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. E8–22066 Filed 9–19–08; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on Reactor Safeguards In accordance with the purposes of Sections 29 and 182b of the Atomic Energy Act (42 U.S.C. 2039, 2232b), the Advisory Committee on Reactor Safeguards (ACRS) will hold a meeting on October 2–4, 2008, 11545 Rockville Pike, Rockville, Maryland. The date of this meeting was previously published in the Federal Register on Monday, October 22, 2007 (72 FR 59574). Thursday, October 2, 2008, Conference Room T–2B3, Two White Flint North, Rockville, Maryland 8:30 a.m.–8:35 a.m.: Opening Remarks by the ACRS Chairman (Open)—The ACRS Chairman will make opening remarks regarding the conduct of the meeting. 8:35 a.m.–10 a.m.: License Renewal Application and Final Safety Evaluation Report (SER) for the Shearon Harris Nuclear Power Plant, Unit 1 (Open)— The Committee will hear a briefing by and hold discussions with representatives of the NRC staff and Carolina Power & Light Company regarding the license renewal application for the Shearon Harris Nuclear Power Plant, Unit 1, and the associated NRC staff’s final SER. 10:15 a.m.–12:15 p.m.: Status of Resolution of Generic Safety Issue (GSI)–191, ‘‘Assessment of Debris Accumulation on Pressurized-Water Reactor (PWR) Sump Performance’’ (Open)—The Committee will hear a briefing by and hold discussions with representatives of the NRC staff and PWR Owners Group regarding the staff E:\FR\FM\22SEN1.SGM 22SEN1

Agencies

[Federal Register Volume 73, Number 184 (Monday, September 22, 2008)]
[Notices]
[Page 54635]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-22066]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) October 27-28, 2008. A sample of 
agenda items to be discussed during the public session includes: (1) 
ACMUI subcommittee reports on cesium chloride (CsCl), permanent implant 
brachytherapy rulemaking, and fingerprinting; (2) Y-90 microsphere 
brachytherapy licensing guidance; (3) potential changes to 10 CFR Parts 
20 and 35; (4) patient needs, concerns, and rights in radiation 
medicine; (5) infiltration of fluorine-18 (F-18) and therapeutic 
radiopharmaceuticals as medical events; (6) status of recommendations 
for modifying training and experience attestation requirements; (7) 
status of technical basis for the Petition for Rulemaking (PRM) 35-20 
(Ritenour) and follow-up; (8) Potential rulemaking and associated 
Regulatory Issue Summary (RIS) regarding multiple RSOs on a medical-use 
license; (9) status of current and future 10 CFR Part 35 rulemaking; 
and (10) medical isotope shortages. A copy of the agenda will be 
available at https://www.nrc.gov/reading-rm/doc-collections/acmui/agenda 
or by e-mailing Ms. Ashley Tull at the contact information below.
    Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of 
Byproduct Material.
    Date and Time for Closed Sessions: October 27, 2008 from 8 a.m. to 
9 a.m. This session will be closed so that ACMUI can discuss internal 
Committee business and receive annual ethics training.
    Date and Time for Open Sessions: October 27, 2008, from 9 a.m. to 5 
p.m. and October 28, 2008, from 8 a.m. to 4 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T-2B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting should contact Ms. Tull using the 
information below.

FOR FURTHER INFORMATION CONTACT: Ashley M. Tull, e-mail: 
ashley.tull@nrc.gov, telephone: (240) 888-7129.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Tull at the contact information listed above. 
All submittals must be received by October 20, 2008, and must pertain 
to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The transcript will be available on ACMUI's Web site (https://
www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about January 
27, 2009. A meeting summary will be available on or about December 11, 
2008.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Tull of their planned attendance.

This meeting will be held in accordance with the Atomic Energy Act of 
1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: September 16, 2008.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E8-22066 Filed 9-19-08; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.